(Q33881828)

English

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Schmidt-Wolf IG

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Finke S

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Trojaneck B

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Denkena A

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lefterova P

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Schwella N

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Heuft HG

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Prange G

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Korte M

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Takeya M

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dorbic T

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Neubauer A

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Wittig B

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Huhn D

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 November 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

81

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1009-1016

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Activated T cells and cytokine-induced CD3+CD56+ killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Cancer and gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Human IL-7: a novel T cell growth factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Regulation of human cytotoxic T lymphocyte development by IL-7.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

5 July 2018

Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

29 October 2018

Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

29 October 2018

Cellular immunotherapy and autologous transplantation for hematologic malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

29 October 2018

Lymphocyte apoptosis: induction by gene transfer techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

29 October 2018

Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362953

29 October 2018

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of murine lymphokine-activated killer cells by recombinant IL-7

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Propagation of large numbers of T cells with natural killer cell markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10576658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6690800

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33881828&oldid=2195922998"